Breast Atypical Lobular Hyperplasia
specificA benign (not cancer) condition in which there are more cells than normal in the breast lobules and the cells look abnormal under a microscope. Having ALH increases the risk of breast cancer.
8
Centers
7
Active Trials
—
Cancer Funding
Top Centers for Breast Atypical Lobular Hyperplasia(8)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 59.1 |
| 2 | University of Michigan Rogel Cancer CenterAnn Arbor, MI NCI Comprehensive Active Research Program | 59.1 |
| 3 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 59.1 |
| 4 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 59.1 |
| 5 | University of Illinois Cancer CenterChicago, IL Active Research Program | 59.1 |
| 6 | Boston University Cancer CenterBoston, MA Active Research Program | 59.1 |
| 7 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 59.1 |
| 8 | Cancer Center at IllinoisUrbana, IL | 36.6 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →